


Healthcare Industry NewsFeed
HSMN NewsFeed - 18 Sep 2017
Tetracore(R) Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler
Tetracore(R) Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler
HSMN NewsFeed - 18 Sep 2017
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
HSMN NewsFeed - 18 Sep 2017
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
HSMN NewsFeed - 14 Sep 2017
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties
HSMN NewsFeed - 14 Sep 2017
Surfacer(R) Inside-Out(R) Access Catheter System to be Showcased at CIRSE 2017 Annual Meeting
Surfacer(R) Inside-Out(R) Access Catheter System to be Showcased at CIRSE 2017 Annual Meeting
HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
HSMN NewsFeed - 12 Sep 2017
T.R.U.E. Test(R) Ready-To-Use Patch Test Receives FDA Approval For Pediatric Use
T.R.U.E. Test(R) Ready-To-Use Patch Test Receives FDA Approval For Pediatric Use
HSMN NewsFeed - 12 Sep 2017
Vasorum Launches Celt ACD(R) Second Generation Vascular Closure Device in the USA
Vasorum Launches Celt ACD(R) Second Generation Vascular Closure Device in the USA
HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
HSMN NewsFeed - 11 Sep 2017
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
HSMN NewsFeed - 11 Sep 2017
VENITI, Inc. Announces Boston Scientific Distribution Agreement For VICI VENOUS STENT(R)
VENITI, Inc. Announces Boston Scientific Distribution Agreement For VICI VENOUS STENT(R)
HSMN NewsFeed - 11 Sep 2017
Zimmer Biomet Announces Global Launch of the Persona(R) Partial Knee System
Zimmer Biomet Announces Global Launch of the Persona(R) Partial Knee System
HSMN NewsFeed - 11 Sep 2017
Oncolytics Biotech(R) Announces the Presentation of REOLYSIN(R) Clinical Data at ESMO 2017 Congress
Oncolytics Biotech(R) Announces the Presentation of REOLYSIN(R) Clinical Data at ESMO 2017 Congress
HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
HSMN NewsFeed - 7 Sep 2017
eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
HSMN NewsFeed - 7 Sep 2017
Spinal Resources, Inc.'s Swedge Pedicle Screw System Receives FDA 510(k) Clearance
Spinal Resources, Inc.'s Swedge Pedicle Screw System Receives FDA 510(k) Clearance
HSMN NewsFeed - 6 Sep 2017
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
HSMN NewsFeed - 6 Sep 2017
SCA Pharmaceuticals Announces the Retirement of Dr. Gene Graves, Founder and Chief Executive Officer
SCA Pharmaceuticals Announces the Retirement of Dr. Gene Graves, Founder and Chief Executive Officer
HSMN NewsFeed - 6 Sep 2017
Gardia Medical Demonstrates Enhanced Safety in Lower Extremity Interventions
Gardia Medical Demonstrates Enhanced Safety in Lower Extremity Interventions
HSMN NewsFeed - 5 Sep 2017
FDA Grants Orphan Drug Status to Cellect's ApoGraft(TM) for Acute GvHD and Chronic GvHD
FDA Grants Orphan Drug Status to Cellect's ApoGraft(TM) for Acute GvHD and Chronic GvHD
